Loading
XT
XPhyto Therapeutics Corp. Stock: price and insider trades · Canada
XPhyto Therapeutics Corp.: what insiders have been doing
XPhyto Therapeutics Corp. is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for XPhyto Therapeutics Corp. The previous disclosure was published on 21 March 2022.
Looking back to 2021, when coverage begins, insiders filed no purchases and 2 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€132,237
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 21 March 2022
Declarations7 total
75,000 shares@ CA$1.0241.5% of flowCommon SharesTSXSEDI:3911024
102,500 shares@ CA$1.0558.5% of flowCommon SharesTSXSEDI:3911028
25,000 shares@ CA$1.00100.0% of flowCommon SharesTSXSEDI:3839016
Common SharesTSXSEDI:3839010
Common SharesTSXSEDI:3839013
Common SharesTSXSEDI:3791953
40,000 shares@ CA$0.70100.0% of flowCommon SharesTSXSEDI:3785227
7 of 7 declarations
About XPhyto Therapeutics Corp.
XPhyto Therapeutics Corp. is a biotechnology company focused on developing diagnostic and therapeutic solutions. It is listed on the Toronto Stock Exchange under the symbol XTSE.
